BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9624547)

  • 1. Antibiotic resistance of pneumococci in Norway.
    Bergan T; Gaustad P; Høiby EA; Berdal BP; Furuberg G; Baann J; Tønjum T
    Int J Antimicrob Agents; 1998 Apr; 10(1):77-81. PubMed ID: 9624547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
    Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
    APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone.
    Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK
    J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
    Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
    Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
    Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients].
    Firat M; Ersoy Y; Eşel D; Bayraktar M; Caylan R; Durmaz R
    Mikrobiyol Bul; 2006 Jul; 40(3):169-77. PubMed ID: 17001845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy.
    Marchese A; Tonoli E; Balistreri G; Debbia E; Schito GC
    Microb Drug Resist; 2000; 6(2):163-70. PubMed ID: 10990272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections.
    Penland RL; Wilhelmus KR
    Cornea; 1998 Mar; 17(2):135-40. PubMed ID: 9520187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
    Dias R; Louro D; Caniça M
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2098-105. PubMed ID: 16723571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal resistance in the UK.
    Goldsmith CE; Moore JE; Murphy PG
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():11-8. PubMed ID: 9484868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
    Klugman KP; Capper T
    J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia, 1993-1995. The Slovenian Meningitis Study Group.
    Cizman M; Paragi M; Jovan-Kuhar N; Gubina M; Orazem A; Pokorn M
    Scand J Infect Dis; 1997; 29(3):251-4. PubMed ID: 9255884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World-wide development of antibiotic resistance in pneumococci.
    Appelbaum PC
    Eur J Clin Microbiol; 1987 Aug; 6(4):367-77. PubMed ID: 3311732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.